 |
3-(4’aminoisoindoline-1′-one)-1-piperidine-2,6-dione |
|---|---|
| Trade Name | Revlimid |
| Orphan Indication | Myelodysplastic syndromes |
| EU Market Approval | EU |
| EU Designation Date | 2004-03-08 00:00:00 |
| Sponsor | Celgene Europe Limited |
| |
3-(4’aminoisoindoline-1′-one)-1-piperidine-2,6-dione |
|---|---|
| Trade Name | Revlimid |
| Orphan Indication | Myelodysplastic syndromes |
| EU Market Approval | EU |
| EU Designation Date | 2004-03-08 00:00:00 |
| Sponsor | Celgene Europe Limited |